您的购物车当前为空
别名 盐酸瑞伐拉赞, YH1885
Revaprazan hydrochloride (YH1885) 是一种新型酸泵拮抗剂,可降低COX-2的表达,在幽门螺杆菌感染中,显著抑制炎症。

Revaprazan hydrochloride (YH1885) 是一种新型酸泵拮抗剂,可降低COX-2的表达,在幽门螺杆菌感染中,显著抑制炎症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 198 | In Stock | |
| 10 mg | ¥ 298 | In Stock | |
| 25 mg | ¥ 596 | In Stock | |
| 50 mg | ¥ 941 | In Stock | |
| 100 mg | ¥ 1,430 | In Stock | |
| 500 mg | ¥ 3,580 | In Stock |
Revaprazan hydrochloride 相关产品
| 产品描述 | Revaprazan hydrochloride (YH1885) is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity. |
| 别名 | 盐酸瑞伐拉赞, YH1885 |
| 分子量 | 398.9 |
| 分子式 | C22H24ClFN4 |
| CAS No. | 178307-42-1 |
| Smiles | Cl.CC1N(CCc2ccccc12)c1nc(Nc2ccc(F)cc2)nc(C)c1C |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 3.99 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.51 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容